Tfg Asset Management Gp Ltd

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 30Value: $396.5MLatest: 2025Q1

TFG Asset Management GP Ltd is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 30 holdings worth $0.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OTLY",
  "AXSM",
  "ACAD",
  "INFA",
  null,
  "LYFT",
  "HBM",
  "SNOW",
  null,
  "ANNX",
  "RLAY",
  "TECX",
  "PHVS",
  "KROS",
  null,
  "AUTL",
  "TARS",
  null,
  null,
  null,
  null,
  null,
  null,
  "PATH",
  null,
  "CXM",
  "IMVT",
  "CCJ",
  "CLDX",
  "BVN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 30
Total Value: 396534527
Accession Number: 0000902664-25-002362
Form Type: 13F-HR
CIK: tfg-asset-management-gp
Manager Name: Tfg-Asset-Management-Gp

Data Enrichment

67% identified

20 identified10 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

30 positions • $396.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

464288513

Shares:1.6M

Value:$126.4M

% of Portfolio:31.9% ($126.4M/$396.5M)

UiPath, Inc.

PATH|90364P105

Shares:8.9M

Value:$92.2M

% of Portfolio:23.2% ($92.2M/$396.5M)

50043K406

Shares:2.7M

Value:$22.4M

% of Portfolio:5.6% ($22.4M/$396.5M)

53680QAA6

Shares:—

Value:$19.3M

% of Portfolio:4.9% ($19.3M/$396.5M)

Sprinklr, Inc.

CXM|85208T107

Shares:2.2M

Value:$18.4M

% of Portfolio:4.6% ($18.4M/$396.5M)

32076VAD5

Shares:—

Value:$15.6M

% of Portfolio:3.9% ($15.6M/$396.5M)

Informatica Inc.

INFA|45674M101

Shares:800.0K

Value:$14.0M

% of Portfolio:3.5% ($14.0M/$396.5M)

Autolus Therapeutics plc

AUTL|05280R100

Shares:8.6M

Value:$13.3M

% of Portfolio:3.4% ($13.3M/$396.5M)

67421JAC2

Shares:—

Value:$12.4M

% of Portfolio:3.1% ($12.4M/$396.5M)

Lyft, Inc.

LYFT|55087P104

Shares:1.0M

Value:$11.9M

% of Portfolio:3.0% ($11.9M/$396.5M)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:178.5K

Value:$9.2M

% of Portfolio:2.3% ($9.2M/$396.5M)

23282WAC4

Shares:—

Value:$5.8M

% of Portfolio:1.5% ($5.8M/$396.5M)

Annexon, Inc.

ANNX|03589W102

Shares:2.6M

Value:$5.1M

% of Portfolio:1.3% ($5.1M/$396.5M)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:261.0K

Value:$4.7M

% of Portfolio:1.2% ($4.7M/$396.5M)

784730AB9

Shares:—

Value:$4.1M

% of Portfolio:1.0% ($4.1M/$396.5M)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:33.8K

Value:$3.9M

% of Portfolio:1.0% ($3.9M/$396.5M)

Tectonic Therapeutic, Inc.

TECX|878972108

Shares:187.5K

Value:$3.3M

% of Portfolio:0.8% ($3.3M/$396.5M)

Immunovant, Inc.

IMVT|45258J102

Shares:131.2K

Value:$2.2M

% of Portfolio:0.6% ($2.2M/$396.5M)

Pharvaris N.V.

PHVS|N69605108

Shares:127.0K

Value:$2.0M

% of Portfolio:0.5% ($2.0M/$396.5M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:183.0K

Value:$1.9M

% of Portfolio:0.5% ($1.9M/$396.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip464288513)✕	1.6M	QoQ +61.51% (+610.1K) YoY +60.19% (+601.9K)	All Managers (Combined)	$126.4M	31.9% ($126.4M/$396.5M)	QoQ +62.00% (+$48.4M) YoY +62.58% (+$48.6M)
UiPath, Inc.(PATHcusip90364P105)	8.9M	QoQ +28.77% (+2.0M) YoY +258.00% (+6.5M)	All Managers (Combined)	$92.2M	23.2% ($92.2M/$396.5M)	QoQ +4.35% (+$3.9M) YoY +62.65% (+$35.5M)
(cusip50043K406)✕	2.7M	QoQ +0.39% (+10.5K) YoY +0.39% (+10.5K)	All Managers (Combined)	$22.4M	5.6% ($22.4M/$396.5M)	QoQ +57.53% (+$8.2M) YoY +167.75% (+$14.0M)
(cusip53680QAA6)✕	—	QoQ - YoY -	All Managers (Combined)	$19.3M	4.9% ($19.3M/$396.5M)	QoQ -3.14% (-$626.9K) YoY -20.47% (-$5.0M)
Sprinklr, Inc.(CXMcusip85208T107)	2.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$18.4M	4.6% ($18.4M/$396.5M)	QoQ -1.18% (-$220.0K) YoY -31.94% (-$8.6M)
(cusip32076VAD5)✕	—	QoQ - YoY -	All Managers (Combined)	$15.6M	3.9% ($15.6M/$396.5M)	QoQ +10.48% (+$1.5M) YoY -46.58% (-$13.6M)
Informatica Inc.(INFAcusip45674M101)	800.0K	QoQ +33.33% (-200.0K) YoY NEW(+800.0K)	All Managers (Combined)	$14.0M	3.5% ($14.0M/$396.5M)	QoQ -10.27% (-$1.6M) YoY NEW(+$14.0M)
Autolus Therapeutics plc(AUTLcusip05280R100)	8.6M	QoQ +4.24% (-350.0K) YoY +14.27% (-1.1M)	All Managers (Combined)	$13.3M	3.4% ($13.3M/$396.5M)	QoQ -31.24% (-$6.1M) YoY -72.23% (-$34.7M)
(cusip67421JAC2)✕	—	QoQ - YoY NEW	All Managers (Combined)	$12.4M	3.1% ($12.4M/$396.5M)	QoQ -12.26% (-$1.7M) YoY NEW(+$12.4M)
Lyft, Inc.(LYFTcusip55087P104)	1.0M	QoQ 0.00% (-0) YoY +66.66% (+400.0K)	All Managers (Combined)	$11.9M	3.0% ($11.9M/$396.5M)	QoQ -7.98% (-$1.0M) YoY +2.23% (+$260.0K)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	178.5K	QoQ -10.76% (-21.5K) YoY -60.34% (-271.5K)	All Managers (Combined)	$9.2M	2.3% ($9.2M/$396.5M)	QoQ -17.21% (-$1.9M) YoY -43.95% (-$7.2M)
(cusip23282WAC4)✕	—	QoQ - YoY -	All Managers (Combined)	$5.8M	1.5% ($5.8M/$396.5M)	QoQ -20.56% (-$1.5M) YoY -81.80% (-$26.0M)
Annexon, Inc.(ANNXcusip03589W102)	2.6M	QoQ +89.28% (-1.3M) YoY NEW(+2.6M)	All Managers (Combined)	$5.1M	1.3% ($5.1M/$396.5M)	QoQ -28.78% (-$2.1M) YoY NEW(+$5.1M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	261.0K	QoQ +35.93% (-69.0K) YoY NEW(+261.0K)	All Managers (Combined)	$4.7M	1.2% ($4.7M/$396.5M)	QoQ -2.36% (-$114.7K) YoY NEW(+$4.7M)
(cusip784730AB9)✕	—	QoQ - YoY -	All Managers (Combined)	$4.1M	1.0% ($4.1M/$396.5M)	QoQ -78.95% (-$15.3M) YoY -66.72% (-$8.2M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	33.8K	QoQ -18.04% (-7.4K) YoY NEW(+33.8K)	All Managers (Combined)	$3.9M	1.0% ($3.9M/$396.5M)	QoQ +12.96% (-$452.6K) YoY NEW(+$3.9M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	187.5K	QoQ NEW(+187.5K) YoY NEW(+187.5K)	All Managers (Combined)	$3.3M	0.8% ($3.3M/$396.5M)	QoQ NEW(+$3.3M) YoY NEW(+$3.3M)
Immunovant, Inc.(IMVTcusip45258J102)	131.2K	QoQ NEW(+131.2K) YoY NEW(+131.2K)	All Managers (Combined)	$2.2M	0.6% ($2.2M/$396.5M)	QoQ NEW(+$2.2M) YoY NEW(+$2.2M)
Pharvaris N.V.(PHVScusipN69605108)	127.0K	QoQ NEW(+127.0K) YoY NEW(+127.0K)	All Managers (Combined)	$2.0M	0.5% ($2.0M/$396.5M)	QoQ NEW(+$2.0M) YoY NEW(+$2.0M)
Keros Therapeutics, Inc.(KROScusip492327101)	183.0K	QoQ +77.66% (+80.0K) YoY NEW(+183.0K)	All Managers (Combined)	$1.9M	0.5% ($1.9M/$396.5M)	QoQ +14.36% (+$234.3K) YoY NEW(+$1.9M)